PGT-SR and Chromosomal Structural Rearrangements: What Translocation Carriers Should Know

PGT-SR is a type of preimplantation genetic testing used for families with chromosomal structural rearrangement risk. Structural rearrangements may include balanced translocations, Robertsonian translocations, inversions or other chromosomal changes. Carriers may be healthy, but embryo formation may involve increased risk of unbalanced chromosomal material.

Families with recurrent pregnancy loss, infertility, abnormal embryo development or known chromosomal rearrangements may be advised to undergo karyotype testing. If a structural rearrangement is confirmed, PGT-SR may be discussed as part of IVF planning.

Balanced translocation means chromosomal material has been rearranged without obvious gain or loss in the carrier. However, during egg or sperm formation, chromosome segregation can create embryos with missing or extra genetic material. Such embryos may fail to develop, fail to implant, miscarry or lead to affected pregnancy.

PGT-SR usually begins with confirmed karyotype information. In an IVF cycle, embryos are cultured and biopsied at an appropriate stage. A genetics laboratory analyzes the biopsy sample using a suitable platform. Results must be interpreted according to the method, resolution, family history and clinical context.

Patients often ask whether PGT-SR can distinguish balanced carrier embryos from embryos with a normal karyotype. The answer depends on the testing strategy and laboratory capability. Some approaches identify unbalanced embryos but may not always distinguish balanced carriers from non-carriers. This should be clarified before testing.

PGT-SR can reduce the likelihood of transferring clearly unbalanced embryos, but it cannot guarantee pregnancy or eliminate all genetic risk. Prenatal screening or diagnosis may still be recommended. Families may also face a lower number of transferable embryos.

Genetic counseling is important for understanding risk, possible results and emotional implications. Cross-border patients should also consider local laws and embryo storage rules.

PGT-SR can be valuable for selected families, but it requires diagnosis, counseling and informed decision-making. This article is for educational purposes only and does not constitute medical advice.